Bernhard Rendenbach

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker et al. · Leukemia · 2020 · 92 citations · Full text

Life Sciences, Hematology, Oncology +16

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV

Manuel Barreto Miranda, Michael Lauseker, M-P Kraus et al. · Leukemia · 2016 · 88 citations · Full text

Medicine, Oncology, Pharmacology +10

Community-driven development of a modified progression-free survival ratio for precision oncology

Andreas Möck, Christoph E. Heilig, Simon Kreutzfeldt et al. · ESMO Open · 2019 · 44 citations · Full text

Medicine, Biostatistics, Oncology +16

Palliative treatment of advanced pancreatic carcinoma in community-based oncology group practices.

H. F. Koeppler, Monika Grundheber, Jochen Heymanns et al. · PubMed · 2004 · 11 citations

Medicine, Oncology, Radiation Oncology +17